- Company Overview for ELEVARA MEDICINES LIMITED (16200589)
- Filing history for ELEVARA MEDICINES LIMITED (16200589)
- People for ELEVARA MEDICINES LIMITED (16200589)
- More for ELEVARA MEDICINES LIMITED (16200589)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
21 Aug 2025 | SH01 |
Statement of capital following an allotment of shares on 13 August 2025
|
|
02 May 2025 | SH10 | Particulars of variation of rights attached to shares | |
25 Apr 2025 | SH01 |
Statement of capital following an allotment of shares on 31 March 2025
|
|
10 Apr 2025 | MA | Memorandum and Articles of Association | |
10 Apr 2025 | RESOLUTIONS |
Resolutions
|
|
04 Apr 2025 | AP01 | Appointment of Ms Emma Jayne Tinsley as a director on 31 March 2025 | |
03 Apr 2025 | AP04 | Appointment of Oakwood Corporate Secretary Limited as a secretary on 2 April 2025 | |
03 Apr 2025 | AA01 | Current accounting period shortened from 31 January 2026 to 31 December 2025 | |
03 Apr 2025 | AD01 | Registered office address changed from 222 Regent Street London W1B 5TR United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 3 April 2025 | |
18 Mar 2025 | PSC02 | Notification of Weatherden Limited as a person with significant control on 5 February 2025 | |
18 Mar 2025 | PSC02 | Notification of Aeon 5 Limited as a person with significant control on 5 February 2025 | |
18 Mar 2025 | PSC01 | Notification of Emma Jayne Tinsley as a person with significant control on 5 February 2025 | |
10 Mar 2025 | PSC09 | Withdrawal of a person with significant control statement on 10 March 2025 | |
18 Feb 2025 | SH01 |
Statement of capital following an allotment of shares on 5 February 2025
|
|
18 Feb 2025 | SH02 | Sub-division of shares on 5 February 2025 | |
18 Feb 2025 | RESOLUTIONS |
Resolutions
|
|
22 Jan 2025 | NEWINC |
Incorporation
Statement of capital on 2025-01-22
|